FONAR CORPFONREarnings & Financial Report
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Revenue
$27.2M
Gross Profit
N/A
Operating Profit
$4.1M
Net Profit
$2.5M
Gross Margin
N/A
Operating Margin
15.2%
Net Margin
9.2%
YoY Growth
5.6%
FONAR CORP Q3 FY2025 Financial Summary
FONAR CORP reported revenue of $27.2M (up 5.6% YoY) for Q3 FY2025, with a net profit of $2.5M (up 33.9% YoY) (9.2% margin).
Key Financial Metrics
| Total Revenue | $27.2M |
|---|---|
| Net Profit | $2.5M |
| Gross Margin | N/A |
| Operating Margin | 15.2% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
FONAR CORP Q3 FY2025 revenue of $27.2M breaks down across 2 segments, led by Health Care Other at $24.8M (91.2% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Health Care Other | $24.8M | 91.2% |
| Manufacturing And Service Of MRI Equipment | $2.4M | 8.8% |
FONAR CORP Annual Revenue by Year
FONAR CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $104.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $104.4M |
| 2024 | $102.9M |
| 2023 | $98.6M |
| 2022 | $97.6M |
FONAR CORP Quarterly Revenue & Net Profit History
FONAR CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $25.5M | +2.4% | $2.1M | 8.0% |
| Q1 FY2026 | $26.0M | +4.3% | $2.3M | 8.7% |
| Q4 FY2025 | $27.3M | +5.1% | $729.3K | 2.7% |
| Q3 FY2025 | $27.2M | +5.6% | $2.5M | 9.2% |
| Q2 FY2025 | $24.9M | -1.7% | $2.0M | 7.9% |
| Q1 FY2025 | $25.0M | -3.4% | $3.1M | 12.6% |
| Q4 FY2024 | $25.9M | +0.6% | $830.4K | 3.2% |
| Q3 FY2024 | $25.7M | +1.2% | $1.9M | 7.3% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.7M | $25.9M | $25.0M | $24.9M | $27.2M | $27.3M | $26.0M | $25.5M |
| YoY Growth | 1.2% | 0.6% | -3.4% | -1.7% | 5.6% | 5.1% | 4.3% | 2.4% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $209.6M | $214.2M | $212.3M | $208.0M | $214.9M | $216.9M | $218.4M | $217.2M |
| Liabilities | $52.6M | $57.5M | $53.5M | $49.0M | $54.7M | $56.8M | $57.0M | $54.4M |
| Equity | $165.8M | $166.0M | $168.7M | $169.8M | $171.9M | $172.6M | $174.9M | $176.9M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $2.8M | $4.6M | $1.7M | $2.2M | $3.1M | $4.2M | $1.7M | $171000 |